Key Highlights: Implications: Granules India’s ₹2,000 crore investment signals an aggressive shift toward higher-margin, complex generics, oncology and peptide CDMO, reducing reliance on commodi...
Key Highlights: Implications: The all-cash ₹188 crore acquisition gives Alivira immediate access to BioForLife’s established Italian pet-care business in nutraceuticals...
